Dr. Eugene R. Ahn, MD

Dr. Ahn practices at Loyola Medicine Pediatric Mobile Health Unit in Maywood, Illinois.

Dr. Ahn's NPI, 1093911307, was assigned on June 23, 2007. Dr. Ahn graduated from University of Miami, Miller School of Medicine in 1997. Dr. Ahn holds Illinois license 036.136519.

Dr. Ahn's primary practice is Loyola Medicine Pediatric Mobile Health Unit, at 2160 S 1st Avenue, Maywood, IL 60153. The practice phone is (708) 216-3299.

Dr. Ahn's primary practice is Loyola Medicine Pediatric Mobile Health Unit in Maywood, Illinois. Dr. Ahn is also affiliated with Loyola University Medical Center. The medical group on file is Loyola University Medical Center. Dmand AI also links Dr. Ahn to 1 more group practice or clinic and 1 medical group, each named with a free account. Dr. Ahn's employer is on file too: a clinical lab.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ahn practices, 3 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Ahn's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Ahn is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Ahn's licenses on file in 4 states: Illinois, Iowa, Florida and Utah.

Dmand AI lists breast cancer and lung cancer among the conditions Dr. Ahn treats.

CMS data shows 92 Medicare services from Dr. Ahn across 3 procedure codes in 2024, all of them office visits, for 80 Medicare patients. Medicare paid $8,519 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 80 Medicare patients who saw Dr. Ahn in 2024. The largest group is 65 to 74, with 40 patients. 75% of them have cancer, and 65% have high blood pressure. Their average risk score is 2.03, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ahn's median patient age at 71, with 77% women.

In 2024, Dr. Ahn wrote 185 Medicare Part D claims for 60 patients. 86% of them were for generic drugs. CMS names the drug for 107 of them, across 4 drugs with 11 or more claims each, at $195,436 in total drug cost. In 2023, CMS named 181 claims across 5 drugs.

Dr. Ahn accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 46 papers to Dr. Ahn, published from 2008 to 2024. 2023 was the busiest year, with 4. The most frequent topics are Antineoplastic Agents, Receptor, ErbB-2 and Antineoplastic Combined Chemotherapy Protocols. Dr. Ahn has published most often in JCO Precis Oncol. Dr. Ahn's most frequent co-authors are Richard L. Schilsky, MD, Yeon S. Ahn, MD and Ramya Thota, MBBS.

Dmand AI links Dr. Ahn to 11 clinical trials, 5 of them phase 2 studies. 5 are still active or recruiting. Conditions studied include Breast Neoplasms, Breast Diseases and Thyroid Cancer, Papillary. Eli Lilly and Company sponsors the most, 2. Open Payments lists research payments to Dr. Ahn that name 1 trial.

CMS Open Payments shows 380 general payments to Dr. Ahn from 34 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 76% of the total. R-Pharm US LLC paid the most, $2,027. It also lists 1 research payment totaling $500 in 2021, naming 1 clinical trial.

Dr. Ahn graduated from University of Miami, Miller School of Medicine in 1997. Dr. Ahn is a member of ASCO, NRG Oncology and Society of Integrative Oncology.

Dr. Ahn is in network with 12 carriers, including Aetna, HCSC and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.